Could a common antibiotic beat joint infections?
NCT ID NCT07335627
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the antibiotic clindamycin works as well as other drugs for treating Streptococcus infections in artificial joints. Researchers will compare success rates in 260 adults who had surgery for this infection. The goal is to see if clindamycin can be a good alternative to standard treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Clindamycin (an antibiotic)
- What this could lead to
- If successful, this could confirm clindamycin as a reliable alternative to standard antibiotics for treating Streptococcus infections in artificial joints.
- What could go wrong
- This is an observational study, not a controlled experiment, so results may be less definitive. The success rate depends on many factors, and clindamycin may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPROSTHETIC JOINT INFECTION DUE TO STREPTOCOCCUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Chirurgie Orthopédique Septique - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.